BENZYL 3-HYDROXY-3-METHYLAZEPANE-1-CARBOXYLATE, 95.0%, 500mg

5-Bromo-6-chloro-2,2-difluorobenzo[d][1,3]dioxole, 95.0%, 1g

Diethyl D-(-)-Tartrate>97.0%(GC)25g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(3-chlorobenzyl)pyrrolidine-2-carboxylic acid, 95.0%, 1g

5,10-Dihydrophenazine, 97%, 1g

4-(Dimethylamino)benzylamine dihydrochloride, 95.0%, 5g

Colonne capillaire GC ROTI®Cap-1, 15 m, 0,32 mm, 0,25 µm, 1 pièce(s)

tert-Butyl (S)-4-(Hydroxymethyl)-2,2-dimethyloxazolidine-3-carboxylate>97.0%(GC)1g

1-(5-Aminothiophen-2-yl)ethanone, 98%, 500mg

N-([1,1'-BIPHENYL]-3-YL)-9,9-DIMETHYL-9H-FLUOREN-2-AMINE, 90.0%, 25g

2,4,6-Tris(3,4-dichlorophenyl)-1,3,5,2,4,6-trioxatriborinane, 95%, 25g

4-Methoxyphenyl 3-O-Allyl-2-O-benzyl-4,6-O-benzylidene-beta-D-galactopyranoside>98.0%(HPLC)1g

2-(Dimethoxyphosphoryl)acetic acid, 97%, 1g